Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging microbes & infections 2020-01, Vol.9 (1), p.382-385
Hauptverfasser:	Tian, Xiaolong, Li, Cheng, Huang, Ailing, Xia, Shuai, Lu, Sicong, Shi, Zhengli, Lu, Lu, Jiang, Shibo, Yang, Zhenlin, Wu, Yanling, Ying, Tianlei
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV ACE2 Amino Acid Sequence Antibodies, Monoclonal - immunology Antibodies, Viral - immunology Betacoronavirus - immunology Binding sites Coronavirus Infections Coronaviruses COVID-19 Cross Reactions Humans Letter Monoclonal antibodies monoclonal antibody Pneumonia, Viral Protein Structure, Tertiary Proteins RBD SARS Virus - immunology SARS-CoV SARS-CoV-2 Spike Glycoprotein, Coronavirus - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!